Media Coverage
Trends Paving The Way For An Influx Of Biosimilar Development
Promising broader patient access to critical medicines, biosimilars offer a more cost-effective alternative therapeutic option compared with originator products. With many patents for blockbuster” commercial biologics set to expire in the next few years, biopharma developers have become increasingly drawn to the biosimilars market.
